Tune Therapeutics (Series B)

Funding Details
Awarder
Inbox
Date Award
May 19, 2025
Vertical
Epigenome Editing
Funding URL
View Funding Page

Company Info
Company Description
Tune Therapeutics is a leading epigenome editing company focused on developing innovative therapies through precise epigenetic modifications.
Market
Biotechnology
Location
Durham, North Carolina, USA
Coinvestors
New Enterprise Associates, Yosemite, Regeneron Ventures, Hevolution Foundation

Links
Back to Home Back to Epigenome Editing Deals View Funding Announcement